FluoGuide strengthen its protection on FG001 with the European granting of patent

FluoGuide A/S (“FluoGuide”) is pleased to announce the grant of European patent No. EP3193945 “uPAR targeting peptide for use in peroperative optical imaging of invasive cancer”, which is the core patent protecting FG001 in Europe. The patent protection is valid until September 2034. The FG001 product patent was granted in USA (US10,111,969B2) in 2018.

The release as fetched from its publisher. fluoguide.com ↗